Search

Your search keyword '"Schrier, Robert W."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Schrier, Robert W." Remove constraint Author: "Schrier, Robert W." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
49 results on '"Schrier, Robert W."'

Search Results

1. Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

2. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

6. Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease

7. List of Contributors

10. Supplement to: Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

11. Supplement to: Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

14. Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

15. Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

18. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

22. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations

23. Manual de Nefrologia

24. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials

25. Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease

26. ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing

27. Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials

28. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease

29. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease

31. Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome

32. List of Contributors

33. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial

35. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

37. Closeout of the HALT-PKD trials

39. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

41. Endothelial dysfunction and oxidative stress in polycystic kidney disease

43. Contributors

44. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2and COL4A1Mutations

45. COLABORADORES

46. Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials

47. Endothelial dysfunction and oxidative stress in polycystic kidney disease.

48. List of Contributors

49. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Catalog

Books, media, physical & digital resources